Conmed (CNMD) Cash from Operations (2010 - 2026)

Conmed has reported Cash from Operations for 17 years, with the latest figure at 13472000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 67.56% year-over-year to 13472000.0; the trailing twelve-month figure through Mar 2026 stood at 142627000.0 (down 20.49% YoY), and the FY2025 full-year result was 170689000.0, up 2.23% from the prior year.
• Cash from Operations for Q1 2026 stood at 13472000.0, down from 46335000.0 in the prior quarter.
• The five-year high for Cash from Operations was 56395000.0 in Q4 2023, with the low at 11598000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 29990705.88 across 5 years, with a median of 29134000.0 in 2025.
• Annual changes were most pronounced in 2023 — Cash from Operations tumbled 1272.87% — and 2024, when it jumped 856.98%.
• Conmed's Cash from Operations stood at 11598000.0 in 2022, then surged by 586.25% to 56395000.0 in 2023, then declined by 23.15% to 43338000.0 in 2024, then gained by 6.92% to 46335000.0 in 2025, then tumbled by 70.92% to 13472000.0 in 2026.
• The last three Cash from Operations figures came in at 13472000.0 (Q1 2026), 46335000.0 (Q4 2025), and 53686000.0 (Q3 2025), per Business Quant data.